Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa K Stamp

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Expert Opinion on Biological Therapy|October 20, 2023
What future do biological therapies have in the treatment of gout?Lisa K Stamp, Angelo Gaffo
Nature Reviews. Rheumatology|July 8, 2015
Gout: Why compare the effectiveness of suboptimal gout management?Nicola Dalbeth, Lisa K Stamp
Seminars in Arthritis and Rheumatism|January 14, 2024
Moving urate-lowering therapy in gout beyond guideline recommendationsLisa K Stamp, Nicola Dalbeth
Pharmacogenomics|April 17, 2015
Pharmacogenetic considerations in the treatment of goutRebecca L Roberts, Lisa K Stamp
Pharmacogenomics|October 20, 2011
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseasesLisa K Stamp, Rebecca L Roberts
Drugs & Aging|September 27, 2014
Urate-lowering therapy: current options and future prospects for elderly patients with goutLisa K Stamp, Peter T Chapman
The Lancet. Rheumatology|January 31, 2024
Self-management of gout using a mobile appLisa K Stamp, Angelo L Gaffo
Rheumatology (Oxford, England)|December 23, 2017
How to prevent allopurinol hypersensitivity reactions?Lisa K Stamp, Murray L Barclay
Best Practice & Research. Clinical Rheumatology|April 9, 2020
Allopurinol hypersensitivity: Pathogenesis and preventionLisa K Stamp, Peter T Chapman
Current Rheumatology Reports|January 20, 2012
Gout and organ transplantationLisa K Stamp, Peter T Chapman
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Expert Opinion on Biological Therapy|October 20, 2023
What future do biological therapies have in the treatment of gout?Lisa K Stamp, Angelo Gaffo
Nature Reviews. Rheumatology|July 8, 2015
Gout: Why compare the effectiveness of suboptimal gout management?Nicola Dalbeth, Lisa K Stamp
Seminars in Arthritis and Rheumatism|January 14, 2024
Moving urate-lowering therapy in gout beyond guideline recommendationsLisa K Stamp, Nicola Dalbeth
Pharmacogenomics|April 17, 2015
Pharmacogenetic considerations in the treatment of goutRebecca L Roberts, Lisa K Stamp
Pharmacogenomics|October 20, 2011
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseasesLisa K Stamp, Rebecca L Roberts
Drugs & Aging|September 27, 2014
Urate-lowering therapy: current options and future prospects for elderly patients with goutLisa K Stamp, Peter T Chapman
The Lancet. Rheumatology|January 31, 2024
Self-management of gout using a mobile appLisa K Stamp, Angelo L Gaffo
Rheumatology (Oxford, England)|December 23, 2017
How to prevent allopurinol hypersensitivity reactions?Lisa K Stamp, Murray L Barclay
Best Practice & Research. Clinical Rheumatology|April 9, 2020
Allopurinol hypersensitivity: Pathogenesis and preventionLisa K Stamp, Peter T Chapman
Current Rheumatology Reports|January 20, 2012
Gout and organ transplantationLisa K Stamp, Peter T Chapman
Pageof 30